Del Nido vs Blood Cardioplegia for Heart Muscle Health During CABG
Official title: Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging
Run by Klinički Bolnički Centar Zagreb · NCT07637266 · Data updated 2026-11-12
This study tests whether Del Nido cardioplegia helps preserve heart muscle better than standard blood cardioplegia in people undergoing coronary artery bypass grafting.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Klinički Bolnički Centar Zagreb Academic / other |
| Locations | 2 sites (Zagreb and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | June 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | June 9, 2026 |
| Trial ID | NCT07637266 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with multi-vessel coronary artery disease scheduled for elective, isolated CABG requiring cardiopulmonary bypass and able to undergo MRI.
✕Probably not a fit
Patients with lower risk profiles or anatomy not favoring one cardioplegia approach may see no difference in outcomes.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Patients with multi-vessel coronary artery disease undergoing isolated CABG are randomized to receive either Del Nido or blood cardioplegia during surgery. The primary assessment uses cardiac magnetic resonance imaging to measure myocardial viability, edema, fibrosis, and left ventricular function after surgery. CMR provides a noninvasive, highly sensitive view of how well the heart muscle is preserved with each protection strategy. The trial excludes cases needing other cardiac procedures, off-pump CABG, reduced ejection fraction under 30%, and MRI contraindications. LeadCenter is University Hospital Center Zagreb, with Klinički Bolnički Centar Zagreb as lead sponsor.
Why it matters
Potential benefit: If Del Nido cardioplegia proves superior, patients may experience better preservation of heart muscle and improved postoperative heart function.
How similar studies have gone: Prior data suggest Del Nido provides reliable protection, but few trials have used cardiac MRI to compare strategies directly in adults.
Who can join: the full rules
Show full inclusion / exclusion criteria
Eligibility Criteria: 1\. Patients with multivessel coronary artery disease scheduled for elective coronary artery bypass grafting Exclusion Criteria: 1. Left ventricular ejection fraction \<30% 2. Associated cardiac procedures 3. Off-pump coronary artery bypass grafting 4. Contraindications for MRI 5. Inability to provide consent
Where it's running
-
University Hospital Center Zagreb
Zagreb, Croatia Recruiting -
University Hospital Center Zagreb
Zagreb, Croatia Recruiting
Study contacts
- Principal investigator: Hrvoje Gasparovic — Clinical Hospital Centre Zagreb
- Study coordinator: Hrvoje Gasparovic, MD, PhD
- Email: hrvoje.gasparovic@kbc-zagreb.hr
- Phone: +385 1 236 7529
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nonintubated anesthesia for adults undergoing cardiac surgery with bypass
This trial tests a nonintubated airway approach with the goal of seeing if avoiding endotracheal intubation during elective valve or bypass surgery can reduce lung problems and help patients recover faster.
-
Early breathing therapy just one hour after CABG extubation
This trial tests whether starting respiratory physiotherapy one hour after extubation improves recovery for adults after elective CABG compared with starting on the first postoperative day.
-
Structured inpatient physiotherapy before and after CABG for high-risk patients
This trial tests whether starting a structured inpatient physiotherapy program at least two days before CABG and continuing after surgery helps high-risk patients recover faster than the same program used only after surgery.
-
Low-dose IL-2 after heart attack to study tissue-resident regulatory T cells
Researchers are testing whether low-dose interleukin-2 given after a myocardial infarction can boost tissue-resident regulatory T cells to support heart repair.
-
Using blood flow measurements during bypass surgery to predict graft openness and recovery
This trial will test whether using a device that measures blood flow during coronary bypass surgery helps surgeons ensure grafts stay open and improves recovery for adults having their first non-emergency multivessel CABG.
-
Predicting major heart problems after coronary artery bypass grafting in people with heart failure
This study will test whether a blood marker called GDF-15 taken before bypass surgery can help predict major heart events over the year after CABG in patients with chronic heart failure and coronary artery disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.